SCHEMBL24254587

SCHEMBL24254587

Cc1ccc(S(=O)(=O)N(C)C)cc1NC(=O)CCc1cccc(CN(C)S(=O)(=O)c2ccc(C)c(NC(=O)Cc3ccc(O)cc3)c2)c1

nearest known ligand 0.65

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.65
RAB9A P51151 1/20 0.50
LMNA P02545 7/20 0.47
POLB P06746 1/20 0.45
GAA P10253 2/20 0.45
PKM P14618 2/20 0.45
KCNJ6 P48051 1/20 0.44
KCNJ5 P48544 1/20 0.44
KCNJ3 P48549 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
CTSD P07339 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
HSD17B1 P14061 1/20 0.42
HSD17B2 P37059 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24254504 0.85 ALDH1A1 (0.63) ALDH1A1RAB9ALMNAPOLBGAA
SCHEMBL24254495 0.80 ALDH1A1 (1.00) ALDH1A1RAB9ALMNAPOLBGAA
SCHEMBL24254500 0.80 ALDH1A1 (0.78) ALDH1A1RAB9ALMNAGAAPKM
SCHEMBL26188047 0.77 ALDH1A1 (0.67) ALDH1A1RAB9ALMNAPOLBGAA
SCHEMBL24254509 0.76 ALDH1A1 (0.69) ALDH1A1RAB9ALMNAGAAPKM
SCHEMBL26188145 0.75 ALDH1A1 (0.64) ALDH1A1RAB9ALMNAPOLBGAA
SCHEMBL26188049 0.75 ALDH1A1 (0.64) ALDH1A1RAB9ALMNAGAAPKM
SCHEMBL26188046 0.73 ALDH1A1 (0.58) ALDH1A1RAB9ALMNAPOLBGAA
SCHEMBL24254501 0.73 CTSD (0.62) ALDH1A1LMNAGAAPKMCTSD
SCHEMBL24254502 0.72 ALDH1A1 (0.66) ALDH1A1RAB9ALMNAPOLBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022035804-A1 SUBSTITUTED 3-AMINO-4-METHYLBENZENESULFONAMIDES AS SMALL MOLECULE INHIBITORS OF UBIQUITIN-SPECIFIC PROTEASE 28 DANA-FARBER CANCER INSTITUTE, INC. (US) 2022-02-17 WO disclosed